Literature DB >> 19193839

Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay.

Klaus Korn1, Benedikt Weissbrich, Cornelia Henke-Gendo, Albert Heim, Christin Mariel Jauer, Ninon Taylor, Josef Eberle.   

Abstract

Systematic sequence analysis of human immunodeficiency virus type 1 (HIV-1) variants with RNA levels underestimated by the Cobas TaqMan HIV-1 assay demonstrated that mutations at a single position of the downstream primer can lead to the underestimation of HIV-1 RNA levels by more than 2 log and to false-negative results in minipool screening of blood donors. Mutations at this position are found in about 2% of all HIV-1 M gag sequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193839      PMCID: PMC2668364          DOI: 10.1128/JCM.02204-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals.

Authors:  P Colson; C Solas; J Moreau; A Motte; M Henry; C Tamalet
Journal:  J Clin Virol       Date:  2007-05-25       Impact factor: 3.168

2.  Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.

Authors:  Jan Felix Drexler; Luciano Kleber de Souza Luna; Celia Pedroso; Diana Brasil Pedral-Sampaio; Artur T L Queiroz; Carlos Brites; Eduardo M Netto; Christian Drosten
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

3.  Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.

Authors:  F Damond; B Roquebert; A Bénard; G Collin; M Miceli; P Yéni; F Brun-Vezinet; D Descamps
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

  3 in total
  19 in total

1.  Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

Authors:  Michael Chudy; Julia Kress; Jochen Halbauer; Margarethe Heiden; Markus B Funk; C Micha Nübling
Journal:  Transfus Med Hemother       Date:  2013-12-19       Impact factor: 3.747

2.  Results of the Abbott RealTime HIV-1 assay for specimens yielding "target not detected" results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test.

Authors:  N Esther Babady; Jeffrey J Germer; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

3.  Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimens.

Authors:  Gavin A Cloherty; James Rhoads; Thomas P Young; Neil T Parkin; Vera Holzmayer; Lilly Yuen; Carolyn Mullen
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

4.  Evaluation of the Procleix Ultrio Elite Assay and the Panther-System for Individual NAT Screening of Blood, Hematopoietic Stem Cell, Tissue and Organ Donors.

Authors:  Albert Heim
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

5.  Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.

Authors:  Michael T Pyne; Katherine L Brown; David R Hillyard
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

Review 6.  Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.

Authors:  Rajyasree Emmadi; Jerry B Boonyaratanakornkit; Rangaraj Selvarangan; Venkatakrishna Shyamala; Barbara L Zimmer; Laurina Williams; Bonita Bryant; Ted Schutzbank; Michele M Schoonmaker; Jean A Amos Wilson; Leslie Hall; Preeti Pancholi; Kathryn Bernard
Journal:  J Mol Diagn       Date:  2011-08-25       Impact factor: 5.568

7.  Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.

Authors:  Suzan Pas; John W A Rossen; Daniel Schoener; Diana Thamke; Annika Pettersson; Reiner Babiel; Martin Schutten
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

Review 8.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

9.  Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.

Authors:  A De Bel; D Marissens; L Debaisieux; C Liesnard; S Van den Wijngaert; S Lauwers; D Piérard
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

10.  A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.

Authors:  Mark A Baumeister; Nan Zhang; Hilda Beas; Jesse R Brooks; Jesse A Canchola; Carlo Cosenza; Felix Kleshik; Vinod Rampersad; Johan Surtihadi; Thomas R Battersby
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.